{Reference Type}: Journal Article
{Title}: Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment.
{Author}: Karim MM;Butt AS;
{Journal}: World J Gastroenterol
{Volume}: 30
{Issue}: 17
{Year}: 2024 May 7
{Factor}: 5.374
{DOI}: 10.3748/wjg.v30.i17.2371
{Abstract}: The diagnosis of non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease only on the basis of laboratory parameter score such as Hepatic Steatosis Index which includes liver enzymes, gender, basal metabolic index, and presence of diabetic mellitus is not sufficient to exclude other causes of deranged liver enzymes especially medications and autoimmune related liver diseases. As the guideline suggests ultrasound is the preferred first-line diagnostic procedure for imaging of NAFLD, as it provides additional diagnostic information and the combination of biomarkers/scores and transient elastography might confer additional diagnostic accuracy and evident from previous similar studies too.